Sally holds a Doctor of Pharmacy from the University of the Pacific, completed a pediatric pharmacy residency at UC Davis Medical Center, and earned an Executive MBA from the University of California, Irvine. She brings more than 25 years of life sciences leadership and a clinical foundation as a pediatric pharmacist, a unique combination that is ideal for the business development of Prism Care’s nurse-led care management model, and establishing the trust of physician practices.
Sally has led ten high-impact pharmaceutical launches across startup and established organizations and has a track record of building markets and the teams that scale them. She led marketing for the U.S. launch of SKYCLARYS, the first approved treatment for Friedreich’s Ataxia, and contributed to Biogen’s $7.3 billion acquisition of the company. At Allergan, she directed marketing for the launch of BOTOX in urology and created the national physician training program that became the model for BOTOX urology training. Earlier in her career, she shaped the investor narrative for an early-stage transplant company that raised a $10 million Series A.
Today, she leverages her clinical expertise, commercialization experience, and passion for improving patient outcomes to expand Prism Care’s reach and strengthen partnerships that help physicians deliver better care to their patients.